[18] [19] If you experience any suspected adverse reactions to either medication, report them through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk)
Many patients using this insulin algorithm will consume both a late-morning & bedtime snack to reduce the likelihood of hypoglycemia
Across multiple clinical trials, semaglutide has consistently demonstrated: significant reductions in HbA1c (a marker of long-term blood glucose control) clinically meaningful weight loss in many patients improved overall glycemic management when used alongside diet and lifestyle changes These results have led to widespread adoption of semaglutide in modern diabetes care and obesity treatment guidelines
Vomiting is also common when taking semaglutide, with studies suggesting anywhere between 8-30% of participants will experience this at least once
To prevent any potential issues, always use a new needle, clean the skin properly before injecting, rotate injection sites regularly, and never inject into areas that are bruised, scarred, or irritated
